Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-06 Sale |
2021-07-08 7:09 pm |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
85,000 | $25.29 | $2,149,295 | 47,815,127 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-07-01 4:55 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
0 | $0 | 366,483 (Direct) |
View |
| 2021-06-29 Exercise |
2021-06-30 4:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 506,236 (Direct) |
View |
| 2021-06-29 Exercise |
2021-06-30 4:49 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 506,236 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-24 12:26 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
25,298 | $0 | 25,298 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:57 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,053,156 | $0 | 55,658,639 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:50 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
280,839 | $0 | 11,699,072 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:49 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
561,678 | $0 | 500,043 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:47 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
386,152 | $0 | 332,527 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:45 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
182,546 | $0 | 157,196 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:42 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
25,298 | $0 | 25,298 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:39 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
25,298 | $0 | 2,772,027 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:38 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director |
25,298 | $0 | 25,298 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:37 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Malley Thomas Director |
25,298 | $0 | 64,580 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:35 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director |
25,298 | $0 | 25,298 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:34 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | su Jingshyh S Director |
25,298 | $0 | 25,298 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:12 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
50,596 | $0 | 11,758,920 (Indirect) |
View |
| 2021-06-09 Exercise |
2021-06-11 4:36 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
6,000 | $31.59 | 414,720 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-11 4:36 pm |
N/A 2026-02-08 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
78,000 | $0 | 414,720 (Direct) |
View |
| 2021-06-03 Gift |
2021-06-07 5:07 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
7,400 | $0 | 2,746,729 (Direct) |
View |
| 2021-06-01 Gift |
2021-06-03 4:51 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
69,000 | $0 | 2,754,129 (Direct) |
View |
| 2021-05-31 Option Award |
2021-06-02 4:40 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
7,729 | $0 | 227,075 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-02 4:40 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 227,075 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-02 4:40 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 227,075 (Direct) |
View |
| 2021-05-27 Gift |
2021-06-01 5:10 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
4,700 | $0 | 2,823,129 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
47,503 | $0.13 | 5,670,966 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:32 pm |
N/A 2021-05-20 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
88,231 | $0 | 5,670,966 (Direct) |
View |
| 2021-04-29 Exercise |
2021-05-03 4:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 532,158 (Direct) |
View |
| 2021-04-29 Exercise |
2021-05-03 4:35 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 532,158 (Direct) |
View |
Ownership |
2021-04-09 4:36 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
0 | $0 | 2,885,987 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-31 4:46 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 551,658 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-31 4:46 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 551,658 (Direct) |
View |
| 2021-03-12 Gift |
2021-03-16 4:31 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
80,000 | $0 | 2,827,829 (Direct) |
View |
| 2021-02-26 Exercise |
2021-03-02 4:52 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 571,158 (Direct) |
View |
| 2021-02-26 Exercise |
2021-03-02 4:52 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 571,158 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 4:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 590,658 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 4:49 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 590,658 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 5:04 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
182,000 | $0 | 3,035,515 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 5:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
14,000 | $6.5 | 3,035,515 (Direct) |
View |